What happened:
Rochester-based Minnesota Partnership for Biotechnology and Medical Genomics finds antibody that appears to promote myelin repair.
Why it’s important:
Could reverse damage done to nerves in the brains and spinal cords of multiple sclerosis patients.
What happens next:
ADVERTISEMENT
Antibody will be used in animal studies and clinical trials.
